OHSU Startup Companies

The office of Technology Transfer & Business Development (TTBD) has assisted in the launch of a number of companies based on OHSU research and technologies. Read more about each company and how they’re impacting the community through further development of OHSU innovations.

13 therapeutics

13therapeutics, Inc. is a research and drug development company based on an innovative system for discovery, development, and commercialization of novel anti-inflammatory peptide therapeutics for the treatment of inflammatory and immune dysfunction diseases with unmet medical needs and high commercial potential.


Acute Innovations

Acute Innovations provides implants and instruments for chest wall stabilization surgical procedures. Products are sold globally and include RibLoc(R) Rib Fracture Plating, RibLoc(R) U Plus Chest Wall Plating System, BioBridge(R) Chest Wall Reconstruction Plate, and AcuTie(R) Sternum Closure System.




Advanced PsychSystems

Advanced PsychSystems provides software to facilitate delivery of personalized behavioral health care. 



AMES Technology

AMES Technology Inc. has developed and is bringing to market a new non-invasive, patented technology which has been shown in clinical trials to reduce impairment and improve function in highly disabled stroke patients and incomplete spinal cord injured patients.


APDM Wearable Technologies, a translational research company focused on discovering reliable & sensitive endpoints of disease progression in neurological & chronic conditions by quantifying human movement with wearable sensors. 

Aronora, Inc. is a translational biotechnology company that is developing safe proprietary antithrombotic (“blood-thinning”) biological drugs.


Artielle Immunotherapeutics, Inc. is developing a novel, first-in-class platform of biological molecules to treat inflammatory and degenerative diseases.


BioSpeech, Inc. is creating speech technology based software solutions for people with language, speech, hearing, breathing problems.


CBDS Health

CBDS Health, Inc. is a complete solution for the Internet of Medical Things (IoMT) with early application focus in research, clinical trials and precision medicine.

Ceremod, Inc. is an Oregon research and development company focused on implantable deep brain stimulation (DBS) devices to treat a variety of medical conditions. Ceremod's focus is to develop DBS as a treatment of severe obesity.



Cylerus, Inc. is developing an implantable, sirolimus-eluting cuff and reservoir system to solve the clinical problem of vascular graft failure. 
Fennec Logo

Fennec Pharmaceuticals, Inc., is a specialty pharmaceutical company focused on the development of Sodium Thiosulfate (STS) for  the prevention of platinum-induced ototoxicity in pediatric patients. STS has received Orphan Drug Designation in the US in this setting.



                      Genefac, Inc. is a Mass Transcription Factor analysis company.




GoBiquity, Inc. provides innovative mobile technology and diagnostics bringing actionable specialty testing to primary care, so physicians can be more effective and efficient at providing preventative care and early detection for their patients.


Molecular MD

MolecularMD Corporation develops and commercializes specialty molecular diagnostics for oncology applications. Its tests are designed to allow appropriate selection, monitoring and management of patients treated with molecularly-targeted cancer therapies.



Najit Technologies, Inc. utilizes a novel oxidation-based vaccine production system, HydroVax™, that results in superior vaccine formulations for infectious disease as compared to conventional methods. 




NeuraMedica, LLC. is a medical device startup company specializing in products for neurosurgery.


NeuroVia, Inc. provides small molecule therapeutics for the treatment of neurologic disorders.




Northwest Education Training & Assessment (NwETA), LLC provides superior training and assessment/testing products that we developed and tested extensively in NIH- and CDC-supported research grants. We now offer these products to a wider audience through NwETA, along with training titles developed in our research.



Nzumbe, Inc. provides research services to solve the needs of pharmaceutical companies and accelerate the development of breakthrough therapies in challenging diseases such as cancer and psychiatric disease. Nzumbe's focus is on preventing and reversing the epigenetic causes of disease.



ReelDx is a HIPAA-compliant, cloud-based platform that enables the secure creation, storage and sharing of medical videos for a variety of applications.



SimHealth Group, LLC is a full service simulation facility design, instructor training, program assessment, development, and implementation group, founded in 2005 by Michael Seropian MD and Bonnie Driggers RN, MS, MPA. The company strives to provide premier professional services to their client and are committed to the integration of simulation into healthcare.



TomegaVax, Inc. is an immunotherapy company developing a platform to use cytomegalovirus vectors to develop both prophylactic and therapeutic vaccines to important infectious diseases. The platform makes possible long term effector memory T cell responses to a variety of pathogens and TomegaVax has vaccines to HIV (prophylactic and therapeutic), Hepatitis B (therapeutic), HPV (therapeutic) and HSV2 (therapeutic) under development.



UbiVac CMV, Inc. is a clinical stage cancer immunotherapy company, advancing platform therapeutics developed at the Earle A. Chiles Research Institute at Providence Portland Medical Center, Oregon Health & Science University, and Portland State University.




Urology Diagnostics, Inc. is an early stage genomics company developing enhanced methods for monitoring an individuals genome through their urine. Early applications of their technology are being applied to detection and monitoring of cancers and screening diagnostics to support early detection and prevention of disease. 



Virogenomics Biodevelopment, Inc. partners with inventors of early pre-clinical stage technologies in order to evaluate and develop commercial products. Virogenomics works closely with inventors until the technology becomes attractive to larger investment.



ViTi, Inc. was formed to improve T cell diagnostic technology. The company is currently developing diagnostic technologies for infectious diseases with a focus on tuberculosis.



Yecuris, Inc. is a Portland, Oregon-based biotechnology company focused on the utilization of humanized model systems for preclinical drug development and human disease modeling.